Key result
Cardiomyocyte-specific deletion of Kdm8 in mice caused progressive dilated cardiomyopathy and lethal heart failure by derepressing Tbx15 and depleting NAD+, which was prevented by NAD+ supplementation.
Why the study?
Cardiac metabolism is deranged in heart failure, but the underlying mechanisms remain unclear.
Does NAD+ supplementation prevent dilated cardiomyopathy in Kdm8 mutant mice?
Does NAD+ supplementation prevent dilated cardiomyopathy in Kdm8 mutant mice?
Epigenetic regulation by KDM8 maintains cardiac metabolism by repressing TBX15, and NAD+ supplementation prevents the initiation of dilated cardiomyopathy in Kdm8-deficient mice.
NAD+ supplementation may merit testing in cardiomyopathy models; leaves open relevance of Kdm8-Tbx15 to human heart failure.
Cardiac metabolism is deranged in heart failure, but underlying mechanisms remain unclear. Here, we show that lysine demethylase 8 (Kdm8) maintains an active mitochondrial gene network by repressing Tbx15 , thus preventing dilated cardiomyopathy leading to lethal heart failure. Deletion of Kdm8 in mouse cardiomyocytes increased H3K36me2 with activation of Tbx15 and repression of target genes in the NAD + pathway before dilated cardiomyopathy initiated. NAD + supplementation prevented dilated cardiomyopathy in Kdm8 mutant mice, and TBX15 overexpression blunted NAD + -activated cardiomyocyte respiration. Furthermore, KDM8 was downregulated in human hearts affected by dilated cardiomyopathy, and higher TBX15 expression defines a subgroup of affected hearts with the strongest downregulation of genes encoding mitochondrial proteins. Thus, KDM8 represses TBX15 to maintain cardiac metabolism. Our results suggest that epigenetic dysregulation of metabolic gene networks initiates myocardium deterioration toward heart failure and could underlie heterogeneity of dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2023) studied Dilated cardiomyopathy. Kdm8 deletion and NAD+ supplementation vs. Wild-type controls and untreated mutants was evaluated on Development of dilated cardiomyopathy and survival. Cardiomyocyte-specific deletion of Kdm8 in mice caused progressive dilated cardiomyopathy and lethal heart failure by derepressing Tbx15 and depleting NAD+, which was prevented by NAD+ supplementation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: